 | • レポートコード：MRC2312MG08377 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、69ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のカスタムポリクローナル抗体開発・製造サービス市場規模と予測を収録しています。・世界のカスタムポリクローナル抗体開発・製造サービス市場：売上、2018年-2023年、2024年-2029年 ・世界のカスタムポリクローナル抗体開発・製造サービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のカスタムポリクローナル抗体開発・製造サービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「小規模」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 カスタムポリクローナル抗体開発・製造サービスのグローバル主要企業は、Eurogentec、 Leadgene Biomedical, Inc.、 Biosynth、 Fortis Life Sciences、 ProteoGenix、 Pacific Immunology、 Rockland、 Abbiotec、 Cayman Chemical Company、 Creative Biolabs、 ProSci、 Sino Biological, Inc.、 GenScript ProBio、 Thermo Fisher Scientificなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、カスタムポリクローナル抗体開発・製造サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のカスタムポリクローナル抗体開発・製造サービス市場：タイプ別、2018年-2023年、2024年-2029年 世界のカスタムポリクローナル抗体開発・製造サービス市場：タイプ別市場シェア、2022年 ・小規模、中規模、大規模 世界のカスタムポリクローナル抗体開発・製造サービス市場：用途別、2018年-2023年、2024年-2029年 世界のカスタムポリクローナル抗体開発・製造サービス市場：用途別市場シェア、2022年 ・病院、研究所、製薬&バイオ企業、その他 世界のカスタムポリクローナル抗体開発・製造サービス市場：地域・国別、2018年-2023年、2024年-2029年 世界のカスタムポリクローナル抗体開発・製造サービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるカスタムポリクローナル抗体開発・製造サービスのグローバル売上、2018年-2023年 ・主要企業におけるカスタムポリクローナル抗体開発・製造サービスのグローバル売上シェア、2022年 ・主要企業におけるカスタムポリクローナル抗体開発・製造サービスのグローバル販売量、2018年-2023年 ・主要企業におけるカスタムポリクローナル抗体開発・製造サービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Eurogentec、 Leadgene Biomedical, Inc.、 Biosynth、 Fortis Life Sciences、 ProteoGenix、 Pacific Immunology、 Rockland、 Abbiotec、 Cayman Chemical Company、 Creative Biolabs、 ProSci、 Sino Biological, Inc.、 GenScript ProBio、 Thermo Fisher Scientific ************************************************************* ・調査・分析レポートの概要 カスタムポリクローナル抗体開発・製造サービス市場の定義 市場セグメント 世界のカスタムポリクローナル抗体開発・製造サービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のカスタムポリクローナル抗体開発・製造サービス市場規模 世界のカスタムポリクローナル抗体開発・製造サービス市場規模：2022年 VS 2029年 世界のカスタムポリクローナル抗体開発・製造サービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのカスタムポリクローナル抗体開発・製造サービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のカスタムポリクローナル抗体開発・製造サービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：小規模、中規模、大規模 カスタムポリクローナル抗体開発・製造サービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究所、製薬&バイオ企業、その他 カスタムポリクローナル抗体開発・製造サービスの用途別グローバル売上・予測 ・地域別市場分析 地域別カスタムポリクローナル抗体開発・製造サービス市場規模 2022年と2029年 地域別カスタムポリクローナル抗体開発・製造サービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Eurogentec、 Leadgene Biomedical, Inc.、 Biosynth、 Fortis Life Sciences、 ProteoGenix、 Pacific Immunology、 Rockland、 Abbiotec、 Cayman Chemical Company、 Creative Biolabs、 ProSci、 Sino Biological, Inc.、 GenScript ProBio、 Thermo Fisher Scientific ... |
This research report provides a comprehensive analysis of the Custom Polyclonal Antibody Development and Production Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Custom Polyclonal Antibody Development and Production Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Custom Polyclonal Antibody Development and Production Service, challenges faced by the industry, and potential opportunities for market players.
The global Custom Polyclonal Antibody Development and Production Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Custom Polyclonal Antibody Development and Production Service market presents opportunities for various stakeholders, including Hospital, Research & Academic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Custom Polyclonal Antibody Development and Production Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Custom Polyclonal Antibody Development and Production Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Custom Polyclonal Antibody Development and Production Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Custom Polyclonal Antibody Development and Production Service market.
Market Overview: The report provides a comprehensive overview of the Custom Polyclonal Antibody Development and Production Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small-scale, Medium-scale), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Custom Polyclonal Antibody Development and Production Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Custom Polyclonal Antibody Development and Production Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Custom Polyclonal Antibody Development and Production Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Custom Polyclonal Antibody Development and Production Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Custom Polyclonal Antibody Development and Production Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Custom Polyclonal Antibody Development and Production Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Custom Polyclonal Antibody Development and Production Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Custom Polyclonal Antibody Development and Production Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Custom Polyclonal Antibody Development and Production Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small-scale
Medium-scale
Large-scale
Market segment by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Global Custom Polyclonal Antibody Development and Production Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Eurogentec
Leadgene Biomedical, Inc.
Biosynth
Fortis Life Sciences
ProteoGenix
Pacific Immunology
Rockland
Abbiotec
Cayman Chemical Company
Creative Biolabs
ProSci
Sino Biological, Inc.
GenScript ProBio
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Custom Polyclonal Antibody Development and Production Service, market overview.
Chapter 2: Global Custom Polyclonal Antibody Development and Production Service market size in revenue.
Chapter 3: Detailed analysis of Custom Polyclonal Antibody Development and Production Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Custom Polyclonal Antibody Development and Production Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Custom Polyclonal Antibody Development and Production Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Custom Polyclonal Antibody Development and Production Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Custom Polyclonal Antibody Development and Production Service Overall Market Size
2.1 Global Custom Polyclonal Antibody Development and Production Service Market Size: 2022 VS 2029
2.2 Global Custom Polyclonal Antibody Development and Production Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Custom Polyclonal Antibody Development and Production Service Players in Global Market
3.2 Top Global Custom Polyclonal Antibody Development and Production Service Companies Ranked by Revenue
3.3 Global Custom Polyclonal Antibody Development and Production Service Revenue by Companies
3.4 Top 3 and Top 5 Custom Polyclonal Antibody Development and Production Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Custom Polyclonal Antibody Development and Production Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Custom Polyclonal Antibody Development and Production Service Players in Global Market
3.6.1 List of Global Tier 1 Custom Polyclonal Antibody Development and Production Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Custom Polyclonal Antibody Development and Production Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Custom Polyclonal Antibody Development and Production Service Market Size Markets, 2022 & 2029
4.1.2 Small-scale
4.1.3 Medium-scale
4.1.4 Large-scale
4.2 By Type – Global Custom Polyclonal Antibody Development and Production Service Revenue & Forecasts
4.2.1 By Type – Global Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2023
4.2.2 By Type – Global Custom Polyclonal Antibody Development and Production Service Revenue, 2024-2029
4.2.3 By Type – Global Custom Polyclonal Antibody Development and Production Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Custom Polyclonal Antibody Development and Production Service Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research & Academic Laboratories
5.1.4 Pharmaceutical & Biotechnology Companies
5.1.5 Others
5.2 By Application – Global Custom Polyclonal Antibody Development and Production Service Revenue & Forecasts
5.2.1 By Application – Global Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2023
5.2.2 By Application – Global Custom Polyclonal Antibody Development and Production Service Revenue, 2024-2029
5.2.3 By Application – Global Custom Polyclonal Antibody Development and Production Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Custom Polyclonal Antibody Development and Production Service Market Size, 2022 & 2029
6.2 By Region – Global Custom Polyclonal Antibody Development and Production Service Revenue & Forecasts
6.2.1 By Region – Global Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2023
6.2.2 By Region – Global Custom Polyclonal Antibody Development and Production Service Revenue, 2024-2029
6.2.3 By Region – Global Custom Polyclonal Antibody Development and Production Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2029
6.3.2 US Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.3.3 Canada Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.3.4 Mexico Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2029
6.4.2 Germany Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4.3 France Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4.4 U.K. Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4.5 Italy Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4.6 Russia Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4.7 Nordic Countries Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.4.8 Benelux Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2029
6.5.2 China Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.5.3 Japan Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.5.4 South Korea Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.5.5 Southeast Asia Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.5.6 India Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2029
6.6.2 Brazil Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.6.3 Argentina Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Custom Polyclonal Antibody Development and Production Service Revenue, 2018-2029
6.7.2 Turkey Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.7.3 Israel Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.7.4 Saudi Arabia Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
6.7.5 UAE Custom Polyclonal Antibody Development and Production Service Market Size, 2018-2029
7 Custom Polyclonal Antibody Development and Production Service Companies Profiles
7.1 Eurogentec
7.1.1 Eurogentec Company Summary
7.1.2 Eurogentec Business Overview
7.1.3 Eurogentec Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.1.4 Eurogentec Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.1.5 Eurogentec Key News & Latest Developments
7.2 Leadgene Biomedical, Inc.
7.2.1 Leadgene Biomedical, Inc. Company Summary
7.2.2 Leadgene Biomedical, Inc. Business Overview
7.2.3 Leadgene Biomedical, Inc. Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.2.4 Leadgene Biomedical, Inc. Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.2.5 Leadgene Biomedical, Inc. Key News & Latest Developments
7.3 Biosynth
7.3.1 Biosynth Company Summary
7.3.2 Biosynth Business Overview
7.3.3 Biosynth Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.3.4 Biosynth Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.3.5 Biosynth Key News & Latest Developments
7.4 Fortis Life Sciences
7.4.1 Fortis Life Sciences Company Summary
7.4.2 Fortis Life Sciences Business Overview
7.4.3 Fortis Life Sciences Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.4.4 Fortis Life Sciences Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.4.5 Fortis Life Sciences Key News & Latest Developments
7.5 ProteoGenix
7.5.1 ProteoGenix Company Summary
7.5.2 ProteoGenix Business Overview
7.5.3 ProteoGenix Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.5.4 ProteoGenix Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.5.5 ProteoGenix Key News & Latest Developments
7.6 Pacific Immunology
7.6.1 Pacific Immunology Company Summary
7.6.2 Pacific Immunology Business Overview
7.6.3 Pacific Immunology Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.6.4 Pacific Immunology Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.6.5 Pacific Immunology Key News & Latest Developments
7.7 Rockland
7.7.1 Rockland Company Summary
7.7.2 Rockland Business Overview
7.7.3 Rockland Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.7.4 Rockland Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.7.5 Rockland Key News & Latest Developments
7.8 Abbiotec
7.8.1 Abbiotec Company Summary
7.8.2 Abbiotec Business Overview
7.8.3 Abbiotec Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.8.4 Abbiotec Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.8.5 Abbiotec Key News & Latest Developments
7.9 Cayman Chemical Company
7.9.1 Cayman Chemical Company Company Summary
7.9.2 Cayman Chemical Company Business Overview
7.9.3 Cayman Chemical Company Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.9.4 Cayman Chemical Company Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.9.5 Cayman Chemical Company Key News & Latest Developments
7.10 Creative Biolabs
7.10.1 Creative Biolabs Company Summary
7.10.2 Creative Biolabs Business Overview
7.10.3 Creative Biolabs Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.10.4 Creative Biolabs Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.10.5 Creative Biolabs Key News & Latest Developments
7.11 ProSci
7.11.1 ProSci Company Summary
7.11.2 ProSci Business Overview
7.11.3 ProSci Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.11.4 ProSci Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.11.5 ProSci Key News & Latest Developments
7.12 Sino Biological, Inc.
7.12.1 Sino Biological, Inc. Company Summary
7.12.2 Sino Biological, Inc. Business Overview
7.12.3 Sino Biological, Inc. Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.12.4 Sino Biological, Inc. Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.12.5 Sino Biological, Inc. Key News & Latest Developments
7.13 GenScript ProBio
7.13.1 GenScript ProBio Company Summary
7.13.2 GenScript ProBio Business Overview
7.13.3 GenScript ProBio Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.13.4 GenScript ProBio Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.13.5 GenScript ProBio Key News & Latest Developments
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Custom Polyclonal Antibody Development and Production Service Major Product Offerings
7.14.4 Thermo Fisher Scientific Custom Polyclonal Antibody Development and Production Service Revenue in Global Market (2018-2023)
7.14.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer